Microsoft thinks that artificial intelligence might be one way to fine-tune CRISPR, and resolve what scientists have been working on for a long while.
Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.
Roche Diagnostics and GE Healthcare have announced a collaboration aimed at developing a digital diagnostics platform providing clinical decision platform to support precision medicine.
In a new study, melanoma patients who received immunotherapy while taking a specific type of beta blocker lived longer than patients who received immunotherapy alone, researchers report.
Johnson & Johnson decided to kick start the new year by striking 15 new collaborations to drive the development of novel solutions to impact healthcare.
The first US Food and Drug Administration-approved gene therapy for an inherited disorder will cost you $425,000 per eye.
23andMe have announced a large-scale study designed to uncover the genetic reasons why people respond differently to diet and exercise regimes.
Recent revelations that a U.S. researcher injected Americans with his experimental herpes vaccine without routine safety oversight raised an uproar among scientists and ethicists.
The nausea, and nasty symptoms that come hand in hand with chemotherapy could soon no longer exist, after a recent experiment looks at using sperm to deliver cancer drugs.
Companion DX is one of at least six clinical labs mired in bankruptcy court after Medicare alleged they improperly billed the government for unnecessary tests.
The spread of some STI’s could potentially be dramatically reduced by instructing people to take antibiotics within 24 hours after unprotected sex.
Although the promise of stem cell therapy didn’t fulfill some of its early promises, two small companies are quietly working to change that.
A team of scientists are attempting to use CRISPR to copy unique mutations from affected children into pigs, who are suffering from a genetic disorder.
The Human Rights Watch has questionned the motives behind Chinese authorities collecting DNA samples from the Xinjiang region.
British doctors have seen a breakthrough in heamophilia A, a genetic defect that sees patients not producing a protein to stop bleeding.